169 related articles for article (PubMed ID: 37184260)
1. LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments.
Chen ZX; Liang L; Huang HQ; Li JD; He RQ; Huang ZG; Song R; Chen G; Li JJ; Cai ZW; Huang JA
Cancer Med; 2023 Jun; 12(12):13438-13454. PubMed ID: 37184260
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylcholine acyltransferase 1 altered phospholipid composition and regulated hepatoma progression.
Morita Y; Sakaguchi T; Ikegami K; Goto-Inoue N; Hayasaka T; Hang VT; Tanaka H; Harada T; Shibasaki Y; Suzuki A; Fukumoto K; Inaba K; Murakami M; Setou M; Konno H
J Hepatol; 2013 Aug; 59(2):292-9. PubMed ID: 23567080
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway.
Shen L; Gu P; Qiu C; Ding WT; Zhang L; Cao WY; Li ZY; Yan B; Sun X
Ann Hepatol; 2022; 27(3):100680. PubMed ID: 35108614
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
Sun Q; Fu C; Liu J; Li S; Zheng J
Ann Clin Lab Sci; 2023 Mar; 53(2):212-221. PubMed ID: 37094849
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
[TBL] [Abstract][Full Text] [Related]
7. LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production.
Han C; Yu G; Mao Y; Song S; Li L; Zhou L; Wang Z; Liu Y; Li M; Xu B
PLoS One; 2020; 15(11):e0240801. PubMed ID: 33137125
[TBL] [Abstract][Full Text] [Related]
8. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
9. LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma.
Li L; Wang X; Ding Y; Hui N; Su B; Yang M
Eur J Med Res; 2022 Oct; 27(1):216. PubMed ID: 36307879
[TBL] [Abstract][Full Text] [Related]
10. LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling.
Gao F; Chen J; Zhang T; Liu N
Exp Cell Res; 2022 Dec; 421(1):113360. PubMed ID: 36122769
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer.
Lebok P; von Hassel A; Meiners J; Hube-Magg C; Simon R; Höflmayer D; Hinsch A; Dum D; Fraune C; Göbel C; Möller K; Sauter G; Jacobsen F; Büscheck F; Prien K; Krech T; Krech RH; von der Assen A; Wölber L; Witzel I; Schmalfeldt B; Geist S; Paluchoswski P; Wilke C; Heilenkötter U; Terracciano L; Müller V; Wilczak W; Burandt EC
Aging (Albany NY); 2019 Sep; 11(18):7796-7804. PubMed ID: 31533087
[TBL] [Abstract][Full Text] [Related]
12. [HECTD2 Represses Cell Proliferation in Colorectal Cancer through Driving Ubiquitination and Degradation of LPCAT1].
Ma L; Li DH; Xu Z
Mol Biol (Mosk); 2022; 56(4):574-584. PubMed ID: 35964314
[TBL] [Abstract][Full Text] [Related]
13. Acyl-CoA:lysophosphatidylcholine acyltransferase I (Lpcat1) catalyzes histone protein O-palmitoylation to regulate mRNA synthesis.
Zou C; Ellis BM; Smith RM; Chen BB; Zhao Y; Mallampalli RK
J Biol Chem; 2011 Aug; 286(32):28019-25. PubMed ID: 21685381
[TBL] [Abstract][Full Text] [Related]
14. LPCAT1 promotes melanoma cell proliferation via Akt signaling.
Wang Y; Huang Y; Wang Y; Zhang W; Wang N; Bai R; Luo R; Tuo H; Zheng Y
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38551165
[TBL] [Abstract][Full Text] [Related]
15. The expression level of lysophosphatidylcholine acyltransferase 1 (LPCAT1) correlates to the progression of prostate cancer.
Zhou X; Lawrence TJ; He Z; Pound CR; Mao J; Bigler SA
Exp Mol Pathol; 2012 Feb; 92(1):105-10. PubMed ID: 22101258
[TBL] [Abstract][Full Text] [Related]
16. Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
Abdelzaher Ahmed E; Abdel Bary Abdel-Latif A; Fahmy AM; Elzarrouk Mania I
J Histotechnol; 2021 Dec; 44(4):196-205. PubMed ID: 34378492
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms regulating lysophosphatidylcholine acyltransferase 1 (LPCAT1) in human pregnancy.
Purandare N; Minchella P; Somayajulu M; Kramer KJ; Zhou J; Adekoya N; Welch RA; Grossman LI; Aras S; Recanati MA
Placenta; 2021 Mar; 106():40-48. PubMed ID: 33618181
[TBL] [Abstract][Full Text] [Related]
18. A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
Cheng L; Han X; Shi Y
Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1276-82. PubMed ID: 19773578
[TBL] [Abstract][Full Text] [Related]
19. Circular RNA circZCCHC6 contributes to tumorigenesis by regulating LPCAT1 via miR-433-3p in non-small cell lung cancer.
Guo Y; Xue W; Sun S; Chen X; Li H; Yan C
Clin Exp Med; 2022 Nov; 22(4):647-659. PubMed ID: 35089454
[TBL] [Abstract][Full Text] [Related]
20. Amniotic fluid LPCAT1 mRNA correlates with the lamellar body count.
Welch RA; Shaw MK; Welch KC
J Perinat Med; 2016 Jul; 44(5):531-2. PubMed ID: 25968427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]